Evolus EOLS
NASDAQ EOLS
$7.41 +0.01 (+0.14%)
At close: Oct 22, 2026 · 4:00 PM EDT

Evolus (EOLS) Long-Term Debt Issuances (2017 - 2026)

Updated

Evolus' Long-Term Debt Issuances came in at $10 million for Q1 2026.

Analysis

Evolus (EOLS) Long-Term Debt Issuances (2017 - 2026) Analysis & Trends

For FY2025, Evolus' Long-Term Debt Issuances was $25 million.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of -9.0% (FY2020 to FY2025).
  • Going back by year, Long-Term Debt Issuances was $50 million in FY2023 and $71.96 million in FY2021 (+79.9%).
  • The Q1 2026 figure represents the lowest quarterly Long-Term Debt Issuances since Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Evolus 486.56 Mn 294.25 Mn 57.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10.00 Mn
Jun 30, 2025 25.00 Mn
Dec 31, 2023 25.00 Mn
Dec 31, 2021 71.96 Mn
Sep 30, 2020 40.00 Mn
Mar 31, 2019 73.91 Mn
Mar 31, 2018 1.13 Mn
Dec 31, 2017 2.29 Mn
Sep 30, 2017 3.43 Mn
Jun 30, 2017 3.21 Mn
Mar 31, 2017 5.39 Mn
API Access

Evolus Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=EOLS&period=max&api_key=YOUR_API_KEY